RecruitingNCT07013344
Association of Plasma N-terminal Pro-Brain Natriuretic Peptide Levels With the Burden of Coronary Artery Disease
Association of Plasma N-terminal Pro-Brain Natriuretic Peptide Levels With the Burden of Coronary Artery Disease: Insights From a Real-World Cohort
Sponsor
IRCCS Ospedale San Raffaele
Enrollment
800 participants
Start Date
Sep 1, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
This study aim to investigate the association between plasma NT-proBNP levels and the presence, extent and severity of stenosis in patients with suspected coronary artery disease.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- patient referred for elective coronary angiography due to suspected CAD.
- NT-proBNP measurement during hospitalization
Exclusion Criteria6
- heart failure
- severe valvular disease
- atrial fibrillation
- severe chronic kidney disease (eGFR < 30 mL/min)
- prior coronary artery bypass grafting
- age over 80 years
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTBNP
Measurement of plasma NT-proBNP level.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07013344
Related Trials
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
NCT0695952450 locations
The Bridging Antiplatelet Therapy With Cangrelor 2 Study
NCT072258421 location
FORWARD CAD IDE Study
NCT0666250034 locations
Prolonged Chest Tube Treatment to Reduce Rates of Atrial Fibrillation Following Cardiac Surgery
NCT068007811 location
Orbital Atherectomy vs Intravascular Lithotripsy for the Treatment of Calcified Coronary Nodules (ORBIT-SHOCK).
NCT067366656 locations